Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance-Letter

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{042feea237e844b8a8aafbd0c714374b,

title = "Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance-Letter",

author = "Sander Bins and Stijn Koolen and Ron Mathijssen",

year = "2019",

doi = "10.1158/1078-0432.Ccr-19-0164",

language = "Undefined/Unknown",

volume = "25",

pages = "3192--3192",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance-Letter

AU - Bins, Sander

AU - Koolen, Stijn

AU - Mathijssen, Ron

PY - 2019

Y1 - 2019

U2 - 10.1158/1078-0432.Ccr-19-0164

DO - 10.1158/1078-0432.Ccr-19-0164

M3 - Article

SN - 1078-0432

VL - 25

SP - 3192

EP - 3192

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -